FTC Report Shows that Oil Sector and Pharmaceutical Sector Mergers Are Under the Antitrust Spotlight

more+
less-

The U.S. Federal Trade Commission (“FTC”) issued a data report on January 4 regarding its horizontal merger investigation and enforcement action record over the past fifteen years. The report shows, sector by-sector, the level of market concentration triggering FTC action, as well as the impact of other antitrust enforcement variables including the presence of hot documents, the presence of strong customer complaints, the number of significant competitors, and entry conditions.

One major take-away from the report is that oil sector and pharmaceutical sector mergers stand out for antitrust scrutiny. Another practical implication of the report’s data is that counsel should place heightened focus on managing document creation and customer communications, both in connection with prospective mergers and in the ordinary course of business.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  FTC, Horizontal Mergers, Oil & Gas, Pharmaceutical

Published In: Antitrust & Trade Regulation Updates, Energy & Utilities Updates, Mergers & Acquisitions Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Dechert LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »